Lifecore biomedical reports fourth quarter and fiscal year end 2024 financial results and provides corporate update

-- recorded revenues of $128.3 million for fiscal 2024; year-over-year increase of 24.2% -- -- high value pipeline continues to advance toward commercialization -- -- state-of-the-art technology enhancements to expand capacity and new business opportunities –

LFCR Ratings Summary

LFCR Quant Ranking